Secreted Wnt antagonists during eradication of cytomegalovirus infection in solid organ transplant recipients

Am J Transplant. 2014 Jan;14(1):210-5. doi: 10.1111/ajt.12506. Epub 2013 Nov 13.

Abstract

We evaluated secreted wingless (Wnt) modulators during cytomegalovirus (CMV) infection in solid organ transplant recipients (SOTr). The major findings were: (i) Plasma levels of Dickkopf-1 (DKK-1) were significantly lower in patients with CMV DNAemia above lower level of quantification at baseline. (ii) Receiver operating characteristic analysis indicated that low DKK-1 and increased secreted frizzled related protein-3 levels were predictors of poor virological outcomes during follow-up. Our findings demonstrate an imbalanced pattern of circulating secreted Wnt modulators in SOTr with poor virological outcomes following treatment for CMV disease, and may suggest a role for dysregulated Wnt signaling on viral pathogenesis during CMV infection.

Trial registration: ClinicalTrials.gov NCT00431353.

Keywords: CMV infection; Wnt signaling; solid organ transplant recipients; virological outcome.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Cytomegalovirus Infections / blood
  • Cytomegalovirus Infections / drug therapy*
  • DNA, Viral / blood
  • Female
  • Humans
  • Intercellular Signaling Peptides and Proteins / blood*
  • Male
  • Middle Aged
  • Organ Transplantation*
  • Proteins / metabolism*
  • Wnt Signaling Pathway / drug effects*
  • Wnt Signaling Pathway / physiology

Substances

  • DKK1 protein, human
  • DNA, Viral
  • Intercellular Signaling Peptides and Proteins
  • Proteins
  • frizzled related protein-3

Associated data

  • ClinicalTrials.gov/NCT00431353